According to GuruFocus Insider Data, the largest insider sells during the past week were: AthenaHealth Inc, Gilead Sciences Inc, JPMorgan Chase & Co, and Walgreen Company.
The overall trend of insiders is illustrated in the chart below:
AthenaHealth, Inc. (ATHN, Financial): Director David Eric Robinson sold 60,000 Shares
Director David Eric Robinson sold 60,000 shares of ATHN stock on 04/14/2014 at the average price of $140.61. David Eric Robinson owns at least 3,692 shares after this. The price of the stock has increased by 3.53% since.
AthenaHealth, Inc is a provider of Internet-based business services for physician practices. AthenaHealth, Inc. has a market cap of $5.44 billion; its shares were traded at around $145.58 with a P/E ratio of 8563.50 and P/S ratio of 9.54. AthenaHealth, Inc. had an annual average earnings growth of 23.90% over the past 5 years.
The company has reported its fourth quarter 2013 results. Total revenues grew by 48% over the prior year quarter. GAAP net income was $13.1 million, or $0.34 per diluted share. Non-GAAP adjusted operating income was $34.1 million.
CEO and President Jonathan Bush sold 1,000 shares of ATHN stock on 04/02/2014 at the average price of $161.74. President, Enterprise Services Stephen N Kahane sold 10,000 shares of ATHN stock on 04/16/2014 at the average price of $143.96. Other insiders have also sold shares of ATHN stock recently.
Gilead Sciences Inc (GILD, Financial): EVP, R&D and CSO Norbert W Bischofberger sold 90,000 Shares
EVP, R&D and CSO Norbert W Bischofberger sold 90,000 shares of GILD stock on 04/14/2014 at the average price of $67.03. Norbert W Bischofberger owns at least 119,302 shares after this. The price of the stock has increased by 4.43% since.
Gilead Sciences, Inc. was incorporated in Delaware on June 22, 1987. Gilead Sciences Inc has a market cap of $107.68 billion; its shares were traded at around $70.00 with a P/E ratio of 38.40 and P/S ratio of 10.59. Gilead Sciences Inc had an annual average earnings growth of 8.20% over the past 5 years.
Gilead Sciences Inc. had reported fourth quarter 2013 sales of $3.04 billion, up 21% compared to sales of $2.51 billion a year ago. Net income was $791.4 million, compared to $762.5 million prior year quarter.
Chairman and CEO John C Martin sold 140,625 shares of GILD stock on 04/01/2014 at the average price of $73.26. EVP Commercial Ops Paul Rutherford Carter, and director John Francis Cogan both also sold shares of GILD stock.
JPMorgan Chase & Co (JPM, Financial): Managing Director Daniel E Pinto sold 98,910 Shares
Managing Director of JPMorgan Chase & Co (JPM, Financial) Daniel E Pinto sold 98,910 shares on 04/14/2014 at an average price of $55.22.
JPMorgan Chase & Co is incorporated under Delaware law in 1968. JPMorgan Chase & Co has a market cap of $209.11 billion; its shares were traded at around $55.22 with a P/E ratio of 12.80 and P/S ratio of 2.18. The dividend yield of JPMorgan Chase & Co stocks is 2.80%. JPMorgan Chase & Co had an annual average earnings growth of 9.30% over the past 10 years.
JPMorgan Chase & Co has recently released its first quarter 2014 results. Quarterly net income was $5.3 billion compared to $6.5 billion in the first quarter of 2013. Revenue was $23.9 billion, a decrease of 8% year-over-year. Return on tangible common equity was 13% compared with 17% in the prior year quarter.
CFO Marianne Lake sold 4,879 shares of JPM stock on 04/14/2014 at the average price of $54.89.General Counsel Stephen M Cutler and multiple other insiders have also sold shares of JPM stock over the past week.
Walgreen Company (WAG, Financial): Pres., Pharmacy, Health & Well Kermit R Crawford sold 74,287 Shares
Pres., Pharmacy, Health & Well Kermit R Crawford sold 74,287 shares of WAG stock on 04/15/2014 at the average price of $66.01. Kermit R Crawford owns at least 90,166 shares after this. The price of the stock has increased by 1.12% since.
Walgreen Company was incorporated in the state of Illinois in 1909 as a successor to a business founded in 1901. Walgreen Company has a market cap of $63.7 billion; its shares were traded at around $66.75 with a P/E ratio of 23.50 and P/S ratio of 0.86. The dividend yield of Walgreen Company stocks is 1.80%. Walgreen Company had an annual average earnings growth of 9.60% over the past 10 years. GuruFocus rated Walgreen Company the business predictability rank of 3.5-star.
Walgreen Co. has released its fiscal second quarter 2014 results ended February 28, 2014. GAAP net income was $754 million ($0.78 per diluted share) for the quarter, compared to income of $756 million ($0.79 per share) last year. Quarterly sales increased 5.1% to $19.6 billion.
SVP, International Robert G Zimmerman sold 26,201 shares of WAG stock on 04/16/2014 at the average price of $66.07.
For the complete list of stocks that bought/sold by their company executives, go to: Insider Buys.
